Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Referanser til kreft i tykk- og endetarm

  1. Heald RJ. The 'holy plane' of rectal surgery. J R Soc Med 1988; 81(9):503-8.
  2. Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, Heald RJ et al. A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45(7):857-66.
  3. Wong CS, Cummings BJ, Brierley JD, Catton CN, McLean M, Catton P et al. Treatment of locally recurrent rectal carcinoma--results and prognostic factors. Int J Radiat Oncol Biol Phys 1998; 40(2):427-35.
  4. Brændengen M, Tveit KM, Hjermstad MJ, Johansson H, Berglund K, Brandberg Y, Glimelius B.Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III study.Eur J Cancer. 2012 April 48;6: 813-9. PMID: 21782418
  5. Folkesson J, Birgisson H, Påhlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005; 23(24):5644-50.
  6. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T et al. The TME Trial After a Median Follow-up of 6 Years: Increased Local Control But No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma. Ann Surg 2007; 246(5):693-701.
  7. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345(9):638-46.
  8. Habr-Gama A, Perez RO, Nadalin W, Nahas S, Ribeiro U, e Sousa AS et al. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg 2005; 9(1):90-9.
  9. Wiig JN, Poulsen JP, Larsen S, Brændengen M, Wæhre H, Giercksky K-E. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer. Eur J Surg 2002; 168(1):42-8.
  10. Law WL, Chu KW, Choi HK. Total pelvic exenteration for locally advanced rectal cancer. J Am Coll Surg 2000; 190(1):78-83.
  11. Wiig JN, Larsen S, Dueland S, Giercksky K-E. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence. Colorectal Dis 2007; Accepted.
  12. Hahnloser D, Nelson H, Gunderson LL, Hassan I, Haddock MG, O`Connell et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003; 237(4):502-8.
  13. Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41(7):1177-89.
  14. Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol 2005; 6(7):477-84.
  15. Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AHM et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 2007; 25(21):3061-8.
  16. Kaminski MF, Regula J. Colorectal cancer screening by colonoscopy--current issues. Digestion 2007; 76(1):20-5.
  17. Wiig JN, Berner A, Tveit KM, Giercksky KE. Evaluation of digitally guided fine needle aspiration cytology versus fine needle core biopsy for the diagnosis of recurrent rectal cancer. Int J Colorect Dis 1996; 11:272-5.
  18. Cancer in Norway 2015, Cancer Registry of Norway, Institute of Population-based Research. Oslo, Norway
  19. Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer. 220. 1994; 15(4):1121–30
  20. Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, Carlsen E, Tveit KM.Late side effects and quality of life after radiotherapy for rectal cancer.Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1005-11. Epub 2009 Jun 18. PMID: 19540058

 Referanser til kirurgidelen

  1. Improving outcomes in colorectal cancers: research evidence for the manual update. London: National Institute for Clinical Excellence; 2004.
  2. Nationella riktlinjer för kolorektalcancersjukvård: medicinskt och hälsoekonomiskt faktadokument. Stockholm: Socialstyrelsen; 2007. Tilgjengelig fra: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/8944/2007-102-3_20071024.pdf
  3. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)Fort Washington, PA: National Comprehensive Cancer Network [oppdatert 2009; lest 2009]. Tilgjengelig fra: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp (krever registrering)
  4. Otchy D, Hyman NH, Simmang C, Anthony T, Buie WD, Cataldo P, et al. Practice parameters for colon cancer. Dis Colon Rectum 2004;47(8):1269–84.
  5. Hohenberger W, Reingruber B, Merkel S. Surgery for colon cancer. Scand J Surg 2003;92(1):45–52.
  6. Kim JC, Lee KH, Yu CS, Kim HC, Kim JR, Chang HM, et al. The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer. Eur J Surg Oncol 2004;30(3):271–9.
  7. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 2005;23(34):8706–12.
  8. Kelder W, Inberg B, Schaapveld M, Karrenbeld A, Grond J, Wiggers T, et al. Impact of the number of histologically examined lymph nodes on prognosis in colon cancer: a population-based study in the Netherlands. Dis Colon Rectum 2009;52(2):260–7.
  9. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003;21(15):2912–9. 134
  10. Rosenberg R, Friederichs J, Schuster T, Gertler R, Maak M, Becker K, et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg 2008;248(6):968–78.
  11. Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Colorectal Dis 2009;11(4):354–64.
  12. Smith AJ, Driman DK, Spithoff K, Hunter A, McLeod RS, Simunovic M, et al. Guideline for optimization of colorectal cancer surgery and pathology. J Surg Oncol 2010;101(5):12.
  13. West NP, Morris EJ, Rotimi O, Cairns A, Finan PJ, Quirke P. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol 2008;9(9):857–65.
  14. West NP, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol 2010;28(2):272–8.
  15. Croner RS, Merkel S, Papadopoulos T, Schellerer V, Hohenberger W, Goehl J. Multivisceral resection for colon carcinoma. Dis Colon Rectum 2009;52(8):1381–6.
  16. Hunter JA, Ryan JA, Jr., Schultz P. En bloc resection of colon cancer adherent to other organs. Am J Surg 1987;154(1):67–71.
  17. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005;365(9472):1718–26.
  18. Hazebroek EJ. COLOR: a randomized clinical trial comparing laparoscopic and open resection for colon cancer. Surg Endosc 2002;16(6):949–53.
  19. Kuhry E, Bonjer HJ, Haglind E, Hop WC, Veldkamp R, Cuesta MA, et al. Impact of hospital case volume on short-term outcome after laparoscopic operation for colonic cancer. Surg Endosc 2005;19(5):687–92.
  20. Kuhry E, Schwenk WF, Gaupset R, Romild U, Bonjer HJ. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev 2008;(2):CD003432.


Prosedyrer i Oncolex kan ikke erstatte faglig veiledning fra kvalifisert veileder. Den som følger prosedyrene har et selvstendig ansvar for at det foreligger nødvendig godkjenning, lisens eller autorisasjon.
Oslo universitetssykehus HF © 2016